Abstract
The authors regret that in the original publication of this article the affiliations of the following authors Abhijit Dey, Biswajit Mukherjee, and Apala Chakraborty were incorrect. Their updated affiliations are as follows: Biswajit Mukherjee, and Apala Chakrabort have the following affiliation: c, Pharmaceutics Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Abhijit Dey has the following affiliation: d, Abhijit Dey, Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India. The authors apologize for any inconvenience caused.
| Original language | English |
|---|---|
| Pages (from-to) | 459 |
| Number of pages | 1 |
| Journal | Journal of Controlled Release |
| Volume | 352 |
| DOIs |
|
| Publication status | Published - Dec 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS